Bioxyne Ltd (ASX: BXN) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Bioxyne Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $114.24 million
P/E Ratio 16.22
Dividend Yield 0.00%
Shares Outstanding 2.24 billion
Earnings per share 0.004
Dividend per share N/A
Year To Date Return 19.05%
Earnings Yield 6.17%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Bioxyne Ltd (ASX: BXN)
Latest News

No posts found.

BXN ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Bioxyne Ltd

Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus fermentum PCC. Some of its products include Breathe Life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange, and others. The company operates in segments, namely, Pharmaceutical manufacture and wholesale supply (business to business), Manufacture and distribution (wholesale, online, and retail), and Wholesale of patented Probiotics.

BXN Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
20 Mar 2026 $0.05 $0.00 0.00% 2,154,774 $0.05 $0.05 $0.05
19 Mar 2026 $0.05 $0.00 0.00% 8,829,038 $0.05 $0.05 $0.05
18 Mar 2026 $0.05 $0.00 0.00% 2,358,574 $0.05 $0.05 $0.05
17 Mar 2026 $0.05 $0.00 0.00% 899,703 $0.05 $0.05 $0.05
16 Mar 2026 $0.05 $-0.01 -18.52% 4,221,525 $0.05 $0.05 $0.05
13 Mar 2026 $0.05 $0.00 0.00% 1,238,919 $0.06 $0.06 $0.05
12 Mar 2026 $0.06 $0.00 0.00% 2,582,219 $0.06 $0.06 $0.05
11 Mar 2026 $0.06 $0.00 0.00% 782,161 $0.06 $0.06 $0.06
10 Mar 2026 $0.06 $0.00 0.00% 1,129,272 $0.06 $0.06 $0.06
09 Mar 2026 $0.05 $0.00 0.00% 6,737,237 $0.06 $0.06 $0.05
06 Mar 2026 $0.06 $0.00 0.00% 1,712,497 $0.06 $0.06 $0.06
05 Mar 2026 $0.06 $0.00 0.00% 2,689,371 $0.06 $0.06 $0.05
04 Mar 2026 $0.06 $0.00 0.00% 4,326,049 $0.06 $0.06 $0.05
03 Mar 2026 $0.06 $0.00 0.00% 3,291,871 $0.06 $0.06 $0.06
02 Mar 2026 $0.06 $0.00 0.00% 6,303,264 $0.06 $0.06 $0.06
27 Feb 2026 $0.06 $0.00 0.00% 12,192,873 $0.06 $0.06 $0.06
26 Feb 2026 $0.06 $0.01 19.23% 21,043,352 $0.06 $0.06 $0.05
25 Feb 2026 $0.05 $0.00 0.00% 6,092,936 $0.05 $0.05 $0.05
24 Feb 2026 $0.05 $0.00 0.00% 6,066,863 $0.05 $0.05 $0.05
23 Feb 2026 $0.05 $0.00 0.00% 2,014,551 $0.05 $0.05 $0.05
20 Feb 2026 $0.05 $0.00 0.00% 1,284,524 $0.05 $0.05 $0.05
19 Feb 2026 $0.05 $0.00 0.00% 2,767,615 $0.05 $0.05 $0.05
18 Feb 2026 $0.05 $0.00 0.00% 868,329 $0.05 $0.05 $0.05

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
24 Dec 2025 Samuel Watson Issued 20,000,000 $840,000
Conversion of securities.
24 Dec 2025 Samuel Watson Issued 39,000,000 $1,638,000
Issue of securities. 39,000,000 Rights
24 Dec 2025 Samuel Watson Exercise 20,000,000 $840,000
Conversion of securities.
24 Dec 2025 Jason Hine Exercise 10,000,000 $420,000
Conversion of securities.
24 Dec 2025 Jason Hine Issued 10,000,000 $420,000
Issue of securities. 10,000,000 performance rights
24 Dec 2025 Jason Hine Issued 10,000,000 $420,000
Conversion of securities.
15 Dec 2025 Jason Hine Issued 200,000 $8,600
Issue of options. Participation in March 2025 Capital Raise
15 Dec 2025 Jason Hine Issued 400,000 $10,000
Issue of securities. Participation in March 2025 Capital Raise
15 Dec 2025 Anthony (Tony) Ho Issued 4,000,000 $100,000
Issue of securities. Participation in March 2027 capital raise
15 Dec 2025 Anthony (Tony) Ho Sell 4,000,000 $172,000
As advised by the company. Gifted to a relative
15 Dec 2025 Anthony (Tony) Ho Issued 2,000,000 $86,000
Issue of options. Participation in March 2027 capital raise
15 Dec 2025 Anthony (Tony) Ho Sell 2,000,000 $86,000
As advised by the company. Gifted to a relative.
27 Oct 2025 Samuel Watson Exercise 13,500,000 $580,500
Conversion of securities. Performance rights 20,000,000
27 Oct 2025 Samuel Watson Issued 13,500,000 $580,500
Conversion of securities.
27 Oct 2025 Jason Hine Exercise 4,500,000 $193,500
Conversion of securities. 10,000,000 performance rights, As per announcement on 27-10-2025
27 Oct 2025 Jason Hine Issued 4,500,000 $193,500
Conversion of securities.
09 Jul 2025 Anthony (Tony) Ho Sell 2,500,000 $43,500
On-market trade.
09 Jul 2025 Anthony (Tony) Ho Transfer 1,500,000 $60,000
Off-market transfer.
09 Jul 2025 Anthony (Tony) Ho Transfer 1,500,000 $60,000
Off-market transfer.
09 Jul 2025 Anthony (Tony) Ho Transfer 4,000,000 $160,000
As advised by the company. Reallocation between accounts
09 Jul 2025 Anthony (Tony) Ho Transfer 4,000,000 $160,000
As advised by the company. Reallocation between accounts
09 Jul 2025 Anthony (Tony) Ho Sell 1,500,000 $43,500
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Anthony (Tony) Peng Ho Non-Executive DirectorNon-Executive Chairman Oct 2012
Mr Ho is an experienced company director having held executive directorships and chief financial officer roles with several ASX listed companies. Tony was executive director of Arthur Yates & Co Limited, retiring from that position in April 2002. His corporate, general management and governance experience includes being chief financial officer/finance director of M.S. McLeod Holdings Limited, Galore Group Limited, the Edward H O'Brien group of companies. Previously, he was a partner of Cox Johnston & Co, Chartered Accountants, which has since merged with Ernst & Young.
Mr Samuel Watson Chief Executive OfficerManaging Director May 2023
Mr Watson since establishing BLS and the Dr Watson Brand in 2018, has become become player in the health and wellness industry in Europe, UK and Japan. In 2020. He is the CEO and founder of Breathe International Ltd.
Mr Jason Hine Executive Director May 2023
Mr Hine was previously the GM Commercial Operations for ECS Botanics Limited. He has been an executive director of several companies spanning manufacturing, power distribution, finance, negotiation, consulting and training industries over a 30 year career.
Mr Guy Adrian Robertson Company Secretary Sep 2016
-
Guy Adrian Robertson Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Breathe International Ltd 576,268,527 28.26%
Kirkman Trading Ltd 157,805,604 7.74%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 130,821,636 6.41%
Mr Christopher Peacock Wilson 83,627,084 4.10%
BPMGMT Ltd 79,493,379 3.90%
Zonetech Wellness Ltd 57,732,857 2.83%
Citicorp Nominees Pty Limited 55,846,056 2.74%
Gavin James Ogilvie 35,528,354 1.74%
Andrew Alexander Ogilvie 35,028,354 1.72%
Paula Ogilvie 33,000,000 1.62%
Grace Investments Fzco 30,000,000 1.47%
Iona Blakeney 24,500,000 1.20%
Mr Anthony Peng Ho & Mrs Chui Hoong Ho 24,390,750 1.20%
Kee Siong Chia 23,050,000 1.13%
Chun Chieh Hsu 20,000,000 0.98%
Mr Makram Hanna & Mrs Rita Hanna <Hanna & Co P/L Super A/C> 17,000,594 0.83%
Southam Investments 2003 Pty Ltd <Warwickshire Investment A/C> 16,721,550 0.82%
Mrs Peng Hyang Ng 15,000,000 0.74%
Mr Jarrad Hand 14,234,001 0.70%
Mr Brett Arthur Bretherton 12,700,000 0.62%

Profile

since

Note